source
- Diagnostic-driven therapies face patient loss due to workflow gaps, new commercialization model proposedThe sponsored article from Diaceutics highlights that while diagnostic-driven therapies are being developed faster than ever, many patients who could benefit never receive them. The authors attribu…
- Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategyResearchers at Mimetic Medicines tested a short lipidated peptide (SLiP) in mice and found it lowered the presence of Nav1.8 sodium channels on sensory neuron membranes. Reducing these channels hel…